Press Releases April 27, 2026 07:00 AM

Astec Announces Quarterly Dividend

Astec Industries Declares Quarterly Dividend of $0.13 per Share

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
ASTE

Astec Industries, a manufacturer of specialized equipment for asphalt road building, aggregate processing, and concrete production, announced a quarterly dividend of $0.13 per share payable on May 29, 2026, to shareholders of record on May 13, 2026. The company operates in two main segments: Infrastructure Solutions and Materials Solutions, and also offers controls and automation products to enhance equipment performance.

Astec Announces Quarterly Dividend
ASTE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Astec declares a stable quarterly dividend of $0.13 per share, reflecting company confidence in steady cash flow.
  • The company manufactures specialized equipment primarily serving the infrastructure construction sector, impacting the industrial machinery and construction materials markets.
  • Astec's business segments focus on road building infrastructure and aggregate processing, highlighting its role in the construction and civil engineering sectors.

CHATTANOOGA, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (NASDAQ: ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on or about May 29, 2026, to shareholders of record as of the close of business on May 13, 2026.

About ASTEC

Astec is a manufacturer of specialized equipment for asphalt road building, aggregate processing and concrete production. Astec's manufacturing operations are divided into two primary business segments: Infrastructure Solutions that includes road building, asphalt and concrete plants, thermal and storage solutions; and Materials Solutions that includes our aggregate processing equipment.

About Astec

Astec, (www.astecindustries.com), is a manufacturer of specialized equipment for asphalt road building, aggregate processing and concrete production. Astec's manufacturing operations are divided into two primary business segments: Infrastructure Solutions that includes road building, asphalt and concrete plants, thermal and storage solutions; and Materials Solutions that include our aggregate processing equipment. Astec also operates a line of controls and automation products designed to deliver enhanced productivity through improved equipment performance.

For more information, visit astecindustries.com and follow us on social media.

LinkedIn https://www.linkedin.com/company/astecindustries/

Facebook https://www.facebook.com/astecindustries

Instagram  https://www.instagram.com/astec_industries/

YouTube https://www.youtube.com/@astec6306/featured

Twitter @astecindustries

Contact:
Stephen C. Anderson
Senior Vice President, Investor Relations
sanderson@astecindustries.com
+1 (423) 899-5898
www.astecindustries.com


Risks

  • Dependence on the infrastructure and construction sectors could expose Astec to cyclical downturns or reduced public/private spending on road and aggregate projects.
  • Market conditions such as commodity price fluctuations and supply chain disruptions could affect production costs and profitability.
  • Technological advancements and automation demands require continuous innovation; failure to keep pace may impact competitiveness.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026